Peptide Receptor Radionuclide Therapy (PRRT) of Neuroendocrine Tumor Patients with Carcinoid Heart Disease

被引：0
|
作者：
Prasad, V [1 ]
Secknus, M. A. [1 ]
Hoersch, D. [1 ]
Kuntze, T. [1 ]
Zachert, C. [1 ]
Baum, R. P. [1 ]
机构：
[1] Zent Klin Bad Berka, Bad Berka, Germany
来源：
NEUROENDOCRINOLOGY | 2009年 / 90卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [1] Prognosis of patients with carcinoid heart disease treated by peptide receptor radionuclide therapy (PRRT)
    Prasad, V.
    Secknus, M. A.
    Hoersch, D.
    Kuntze, T.
    Zachert, C.
    Baum, R. P.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [2] Peptide Receptor Radionuclide Therapy (PRRT) in patients with carcinoid heart disease (Hedinger's syndrome): an efficacy and prognosis study
    Prasad, V.
    Secknus, M.
    Hoersch, D.
    Kuntze, T.
    Zachert, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S231 - S231
  • [3] Retrospective analysis of Peptide Receptor Radionuclide Therapy (PRRT) in Japanese patients with unresectable neuroendocrine tumor.
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Ichikawa, Yasushi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    BLOOD, 2020, 136
  • [5] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
  • [6] TUMOR RESPONSE TO PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) IN A UNITED STATES-BASED NEUROENDOCRINE TUMOR COHORT
    Kipnis, Sarit T.
    Hung, Matthew
    Heckert, Jason
    Bennett, Bonita J.
    Creamer, Caroline
    Eads, Jennifer
    Soulen, Michael C.
    Pryma, Daniel
    Mankoff, David
    Metz, David C.
    Katona, Bryson W.
    GASTROENTEROLOGY, 2020, 158 (06) : S292 - S292
  • [7] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Neuroendocrine Tumors: How Effective and Safe Are They?
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S726
  • [8] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Progressive Grade 3 Neuroendocrine Neoplasms (NEN)
    Zhang, Jingjing
    Kulkarni, Harshad
    Singh, Aviral
    Niepsch, Karin
    Mueller, Dirk
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] Evaluation of toxicity in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S471 - S472
  • [10] Evaluation of Toxicity in Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumors (NET)
    Duan, H.
    Girod, B.
    Ninatti, G.
    Ferri, V
    Kunz, P.
    Fisher, G.
    Moradi, F.
    Davidzon, G.
    Franc, B.
    Lagaru, A.
    Aparici, Mari C.
    NEUROENDOCRINOLOGY, 2020, 110 : 252 - 252
12345